Abstract
Neutral glycolipid and ganglioside compositions were determined on 11 ependymal tumors, 12 medulloblastomas, 6 other neuronal tumors of the brain, 4 peripheral neuroblastomas, 1 cerebral primitive neuroectodermal tumor (PNET), and 1 PNET of the thoracic wall. Within the group of tumors that can demonstrate neuronal phenotypes, there was an association between the degree of neuronal differentiation usually demonstrated by these tumors and the proportions of both GD1a and 1b-pathway gangliosides. The amount of globoside also correlated with the amount of 1b pathway gangliosides. Patients with medulloblastomas whose 1b gangliosides made up over 15% of the total gangliosides survived longer that those with lower proportions of 1b gangliosides. The only gangliosides in the choroid plexus papilloma were GM3 and GD1a, but other ependymal tumors had significant amounts of GD1b and its metabolic precursors. Ependymoma and anaplastic ependymoma had similar neutral glycolipid compositions, which were different from subependymoma, which lacked ceramide monohexoside and ceramide dihexoside. These differences in glycolipid compositions suggest that there may be fundamental biological differences between these types of ependymal tumors.
Similar content being viewed by others
Abbreviations
- CDH:
-
ceramide dihexoside
- CMH:
-
ceramide monohexoside
- C:
-
chloroform
- CTH:
-
ceramide trihexoside
- GA1:
-
asialoGM1
- HPTLC:
-
high-performance thin-layer chromatography
- M:
-
methanol
- NGL:
-
neutral glycolipids
- PNET:
-
primitive neuroectodermal tumor
- TLC:
-
thin-layer chromatography
- W:
-
water
References
Ando S. and Yu R. K. (1977) Isolation and characterization of a novel trisialoganglioside GT1a from human brain.J. Biol. Chem. 252, 6247–6250.
Bailey P. and Cushing H. (1926)A Classification of Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. Lippincott, Philadelphia.
Burger P. C., Grahmann F. C., Bliestle A., and Kleihues P. (1987) Differentiation in the medulloblastoma. A histological and immunohistochemical study.Acta Neuropathol (Berl.) 73, 115–123.
Delattre O., Zugman J., Melot T., Garau X. S., Zucker J.-M., Lenoir G. M., et al. (1994) The Ewing family of tumors-A subgroup of small round-cell tumors defined by specific chimeric transcripts.N. Engl. J. Med. 331, 294–299.
Derry D. M. and Wolfe L. S. (1967) Gangliosides in isolated neurons and glial cells.Science 158, 1452.
Fredman P., von Holst H., Collins V. P., Dellheden B., and Svennerholm L. (1993) Expression of gangliosides GD3 and 3′-isoLM1 in autopsy brains from patients with malignant tumors.J. Neurochem. 60, 99–105.
Gillard B. K., Jones M. A., and Marcus D. M. (1987) Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells.Arch. Biochem. Biophys. 256, 435–445.
Gillard B. K., Heath J. P., Thurmon L. T., and Marcus D. M. (1991) Association of glycosphingolipids with intermediate filaments of human umbilical vein endothelial cells.Exp. Cell Res. 192, 433–444.
Gottfries J., Fredman P., Mansson J.-E., Collins V. P., von Holst H., Armstrong D. D., et al. (1990) Determination of gangliosides in six human primary medulloblastomas.J. Neurochem. 55, 1322–1326.
Gould V. E., Jansson D. S., Molenaar W. M., Rorke L. B., Trojanowski J. Q., Lee V. M. Y., et al. (1990) Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.Lab. Invest. 62, 498–509.
Guzman-Harty M., Warner J. K., Mancini M. E., Pearl D. K., and Yates A. J. (1988) Effect of crush lesion on radiolabelling of ganglioside in rat peripheral nerve.J. Neurochem. 50, 237–242.
Harris G. and MacWilliam I. C. (1954) Dipping technique for revealing sugars on paper chromatograms.Chem. Ind. 249.
Hilbig R., Lauke G., and Rahmann H. (1983) Brain gangliosides during the life span (embryogenesis to senescence) of the rat.Dev. Neurosci. 6, 260–270.
Hirschberg K., Zisling R., Van Echten-Deckert G., and Futerman A. H. (1996) Ganglioside synthesis during the development of neuronal polarity—Major changes occur during axonogenesis and axon elongation, but not during dendrite growth or synaptogenesis.J. Biol. Chem. 271, 14,876–14,882.
Hughes M., Marsden H. B., and Palmer M. K. (1974) Histologic patterns of neuroblastoma.Cancer 34, 1706–1711.
Jennemann R., Mennel H.-D., Bauer B. L., and Wiegandt H. (1994) Glycosphingolipid component profiles of human gliomas correlate with histological tumour types: Analysis of inter-individual and tumour-regional distribution.Acta Neurochir. (Wien.) 126, 170–178.
Joshi V. V., Cantor A. B., Altshuler G., Cohen L. J., Larkin E. W., Shuster J. J., et al. (1996) Conventional versus modified morphologic criteria for ganglioneuroblastoma.Arch. Pathol. Lab. Med. 120, 859–865.
Kanda T., Yoshino H., Ariga T., Yamawaki M., and Yu R. K. (1994) Glycosphingolipid antigens in cultured microvascular bovine brain endothelial cells: Sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy.J. Cell Biol. 126, 235–246.
Kleihues P., Soylemezoglu F., Schäuble B., Scheithauer B. W., and Burger P. C. (1995) Histopathology, classification, and grading of gliomas.Glia 15, 211–221.
Klenk E. (1942) Über die ganglioside, eine neue gruppe von zuckerhaltigen gehirnlipoiden.Hoppe-Seyler’s Z. Physiol. Chem. 273, 76–86.
Ladisch S. and Wu Z.-L. (1985) Detection of a tumor-associated ganglioside in plasma of patients with neuroblastoma.Lancet 1985, 136–138.
Ladisch S., Wu Z.-L., Feig S., Schwartz E., Floutsis G., Wiley F., et al. (1987) Shedding of GD2 ganglioside by human neuroblastoma.Int. J. Cancer 39, 73–76.
Ladisch S., Sweeley C., Becker H., and Gage D. (1989) Aberrant fatty acyl α-hydroxylation in human neuroblastoma tumor gangliosides.J. Biol. Chem. 264, 12,097–12,105.
Lowden J. A. and Wolfe L. S. (1964) Studies on brain gangliosides. III. Evidence for the location of gangliosides specifically in neurones.Can. J. Biochem. 42, 1587–1594.
MacMillan V. H. and Wherrett J. R. (1969) A modified procedure for the analysis of mixtures of tissue gangliosides.J. Neurochem. 16, 1621–1624.
Miettinen T., and Takki-Luukkainen I. T. (1959) Use of butyl acetate in determination of sialic acid.Acta Chem. Scand. 13, 856–885.
Neskovic N., Sarlieve L., Nussbaum J. L., Kostic D., and Mandel P. (1972) Quantitative thin-layer chromatography of glycolipids in animal tissues.Clin. Chim. Acta 38, 147–153.
Rodden F. A., Wiegandt H., and Bauer B. L. (1991) Gangliosides: the relevance of current research to neurosurgery.J. Neurosurg. 74, 606–619.
Saito T. and Hakomori S.-I. (1971) Quantitative isolation of total glycosphingolipids from animal cells.J. Lipid. Res. 12, 257–259.
Schengrund C.-L. and Shochat S. (1988) Gangliosides in neuroblastomas.Neurochem. Pathol. 8, 189–202.
Seyfried T. N., El-Abbadi M., Ecsedy J. A., Bai H. W., and Yohe H. C. (1996) Influence of host cell infiltration on the glycolipid content of mouse brain tumors.J. Neurochem. 66, 2026–2033.
Shimada H. (1993) Tumors of the neuroblastoma group.State of the Art Rev. 2, 43–57.
Singh L. P. K., Franklin T., Aguedlo J. D., Pearl D. K., and Yates A. J. (1991) Neutral glycolipid composition of human astrocytomas.Trans. Am. Soc. Neurochem. 22, 142.
Singh L. P. K., Pearl D. K., Franklin T. K., Spring P. M., Scheithauer B. W., Coons S. W., et al. (1994) Neutral glycolipid composition of primary human brain tumors.Mol. Chem. Neuropathol. 21, 241–257.
Smits A., van Grieken D., Hartman M., Lendahl U., Funa K., and Nister M. (1996) Co-expression of platelet-derived growth factor αand β receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation.Lab. Invest. 74, 188–198.
Sung C. C., Pearl D. K., Coons S. W., Scheithauer B. W., Johnson P. C., and Yates A. J. (1994) Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors.Cancer 74, 3010–3022.
Sung C. C., Pearl D. K., Coons S. W., Scheithauer B. W., Johnson P. C., Zheng M., et al. (1995) Correlation of ganglioside patterns of primary brain tumors with survival.Cancer 75, 851–859.
Svennerholm L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.Biochim. Biophys. Acta 24, 604–611.
Svennerholm L. (1980) Ganglioside designation.Adv. Exp. Med. Biol. 125, 11.
Svennerholm L., Bostrom K., Fredman P., Mansson J.-E., Rosengren B., and Rynmark B.-M. (1989) Human brain gangliosides: Developmental changes from early fetal stage to advanced age.Biochim. Biophys. Acta 1005, 109–117.
Tohyama T., Lee V. M.-Y., Rorke L. B., Marvin M., McKay R. D. G., and Trojanowski J. Q. (1993) Monoclonal antibodies to a rat nestin fusion protein recognize a 220-kDa polypeptide in subsets of fetal and adult human central nervous system neurons and in primitive neuroectodermal tumor cells.Am. J. Pathol. 143, 258–268.
Traylor T. D. and Hogan E. L. (1980) Gangliosides of human cerebral astrocytomas.J. Neurochem. 34, 126–131.
Trojanowski J. Q., Tohyama T., and Lee V. M.-Y. (1992) Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts.Mol. Chem. Neuropathol. 17, 121–135.
Ueno K., Ando S., and Yu R. K. (1978) Gangliosides of human, cat, and rabbit spinal cords and cord myelin.J. Lipid Res. 19, 863–871.
Vanier M. T., Holm M., Ohman R., and Svennerholm L. (1971) Developmental profiles of gangliosides in human and rat brain.J. Neurochem. 18, 581–592.
Washiyama K., Muragaki Y., Rorke L. B., Lee V. M.-Y., Feinstein S. C., Radeke M. J., et al. (1996) Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.Am. J. Pathol. 148, 929–940.
Wiegandt H. (1982) The gangliosides, inAdvances in Neurochemistry, vol. 4, (Agranoff, B. W. and Aprison, M. H., eds.), Plenum, New York, pp. 149–223.
Wu Z.-L., Schwartz E., Seeger R., and Ladisch S. (1986) Expression of GD2 ganglioside by untreated primary human neuroblastomas.Cancer Res. 46, 440–443.
Yates A. J. (1986) Gangliosides in the nervous system during development and regeneration.Neurochem. Pathol. 5, 309–329.
Yates A. J. (1988) Glycolipids and gliomas.Neurochem. Pathol. 8, 157–180.
Yates A. J. and Thompson D. K. (1978) Ganglioside composition of peripheral nerve undergoing Wallerian degeneration.J. Neurochem. 30, 1649–1651.
Yates A. J. and Wherrett J. R. (1974) Changes in the sciatic nerve of the rabbit and its tissue constituents during development.J. Neurochem. 23, 993–1003.
Author information
Authors and Affiliations
Additional information
Ganglioside nomenclature is according to Svennerholm (Ledeen et al., 1988; Svennerholm, 1980).
Rights and permissions
About this article
Cite this article
Yates, A.J., Franklin, T.K., McKinney, P. et al. Gangliosides and neutral glycolipids in ependymal, neuronal and primitive neuroectodermal tumors. J Mol Neurosci 12, 111–121 (1999). https://doi.org/10.1007/BF02736925
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02736925